EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fungal microbiome in gut of systemic lupus erythematosus (SLE)-prone mice (pristane and FCGRIIb deficiency), a possible impact of fungi in lupus

Thanya Cheibchalard, Asada Leelahavanichkul, Piraya Chatthanathon, Piriya Klankeo, Nattiya Hirankarn iD, Naraporn Somboonna iD

PLOS ONE · 05.12.2024 · 19 (12) · e0314662

DOI: 10.1371/journal.pone.0314662 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 05.12.2024. Verfasst von Thanya Cheibchalard und 5 weiteren Autor:innen. Beteiligte Einrichtung: Program in Biotechnology, Faculty of Science, Chulalongkorn University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Gastrointestinal Microbiome, Receptors, IgG. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: College of Pharmacy, Dalhousie University, Chulalongkorn University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut mycobiota (fungal microbiota) plays a crucial role in the immune system, potentially impacting autoimmune diseases such as systemic lupus erythematosus (SLE). Despite growing interest, data on intestinal fungi in SLE remain limited. This study thereby investigated the human-mimicked (mice) gut mycobiome and quantitative gut mycobiome analyses using universal fungal internal transcribed spacer 2 (ITS2) DNA next generation sequencing and real-time PCR, tracking time-series dynamics from preclinical to established SLE conditions in two SLE-prone mouse models. These models included pristane -induced mice, representing an environmental cause of SLE, and Fc gamma receptor RIIb (FcgRIIb) deficiency mice, representing a genetic factor. Fecal samples and different intestinal sections from mice aged 2–10 months were analyzed, including samples from 4-month-old and 11-month-old mice, which represented preclinical lupus (negative for anti-dsDNA) and established SLE conditions (positive for anti-dsDNA with proteinuria), respectively, alongside age-matched healthy controls. Results showed increased fungal diversity, specific changes in gut fungal species (i.e. increased Candida spp.), and an elevated Basidiomycota-to-Ascomycota (Basidiomycota/Ascomycota) ratio, which correlated with lupus activity in both lupus models. Linear discriminant analysis Effect Size (LEfSe; a possible representative organism) helped identify specific fungal difference between the lupus models. Our findings revealed that active lupus states may elevate gut fungal populations and alter fungal components in both the pristane and genetically susceptible SLE-prone mice, as indicated by mycobiota and quantitative mycobiota analyses. These changes could, in turn, influence disease activity. This research is essential for a deeper understand of the SLE-gut microbiome association, as the gut microbiome comprises both bacterial and fungal symbiosis. Manipulating fungal communities could present a potential therapeutic avenue for influencing disease outcomes in lupus. Further studies are crucial to clarify the direct role of gut fungi in lupus disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicGastrointestinal MicrobiomeReceptors, IgGAnimalsMiceMycobiomeDisease Models, AnimalTerpenesFungiFemaleFecesMice, Inbred C57BL

Substanzen

pristaneReceptors, IgGTerpenesFcgr2b protein, mouse

Autor:innen und Institutionen

  • Program in Biotechnology, Faculty of Science, Chulalongkorn University, Bangkok, Thailand.
  • Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Center of Excellence on Translational Research in Inflammation and Immunology (CETRII), Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Department of Microbiology, Faculty of Science, Chulalongkorn University, Bangkok, Thailand.
  • Multi-Omics for Functional Products in Food, Cosmetics and Animals Research Unit, Chulalongkorn University, Bangkok, Thailand.
  • Omics Sciences and Bioinformatics Center, Chulalongkorn University, Bangkok, Thailand.

ORCID-Profile: Nattiya Hirankarn, Naraporn Somboonna

Förderung

  • College of Pharmacy, Dalhousie University
  • Chulalongkorn University

Zitieren

APA

Cheibchalard, T., Leelahavanichkul, A., Chatthanathon, P., Klankeo, P., Hirankarn, N., & Somboonna, N. (2024). Fungal microbiome in gut of systemic lupus erythematosus (SLE)-prone mice (pristane and FCGRIIb deficiency), a possible impact of fungi in lupus. PLOS ONE, 19(12), e0314662. https://doi.org/10.1371/journal.pone.0314662

Vancouver

Cheibchalard T, Leelahavanichkul A, Chatthanathon P, Klankeo P, Hirankarn N, Somboonna N. Fungal microbiome in gut of systemic lupus erythematosus (SLE)-prone mice (pristane and FCGRIIb deficiency), a possible impact of fungi in lupus. PLOS ONE. 2024;19(12):e0314662. doi:10.1371/journal.pone.0314662

BibTeX
@article{Cheibchalard2024,
  author = {Cheibchalard, Thanya and Leelahavanichkul, Asada and Chatthanathon, Piraya and Klankeo, Piriya and Hirankarn, Nattiya and Somboonna, Naraporn},
  title = {Fungal microbiome in gut of systemic lupus erythematosus (SLE)-prone mice (pristane and FCGRIIb deficiency), a possible impact of fungi in lupus},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {12},
  pages = {e0314662},
  doi = {10.1371/journal.pone.0314662}
}
Kostenlos starten →